Ageing, smoking and oxidative stress

Thorax

Volumn 61, Issue 6, 2006, Pages 461-462

  Donohue, J F ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GLUTATHIONE DISULFIDE;

AGING; CARBONYLATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; EDITORIAL; FORCED EXPIRATORY VOLUME; HUMAN; LUNG LAVAGE; OXIDATIVE STRESS; PREVALENCE; PRIORITY JOURNAL; SMOKING CESSATION; TOBACCO;

AGED; AGING; FORCED EXPIRATORY VOLUME; GLUTATHIONE; HUMANS; OXIDATIVE STRESS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING;

EID: 33745155071     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2005.053058     Document Type: Editorial

References (17)

1. Pauwels RA, Rabe KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 2004;364:613-20.
2. Nagai K, Betsuyaku T, Kondo T, et al. Long term smoking with age builds up excessive oxidative stress in bronchoalveolar lavage fluid. Thorax 2006;61:496-502.
3. MacNee W. Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005;2:50-60.
4. Bowler RP, Barnes PJ, Crapo JD. The role of oxidative stress in chronic obstructive pulmonary disease. COPD 2004;1:255-77.
5. Kinnula VL. Focus on antioxidant enzymes and antioxidant strategies in smoking related airway disease. Thorax 2005;60:693-700.
6. Di Stefano A, Caramori G, Ricciardolo FL, et al. Cellular and molecular mechanisms in chronic obstructive pulmonary disease: an overview. Clin Exp Allergy 2004;34:1156-67.
7. Hogg JC, Chu F, Utokaparch S, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004;350:2645-53.
8. Hodge S, Hodge G, Holmes M, et al. Increased airway epithelial and T-cell apoptosis in COPD remains despite smoking cessation. Eur Respir J 2005;25:447-54.
9. Morris A, Sciurba FC, Lebedeva IP. Association of chronic obstructive pulmonary disease severity and pneumocystis colonization. Am J Respir Crit Care Med 2004;170:408-13.
10. Retamales I, Elliott WM, Meshi B, et al. Amplification of inflammation in emphysema and its association with latent adenoviral infection. Am J Respir Crit Care Med 2001;164:469-73.
11. Agusti A, MacNee W, Donaldson K. Hypothesis: Does COPD have an autoimmune component? Thorax 2003;58:832-4.
12. Willemse BW, ten Hacken NH, Rutgers B, et al. Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers. Eur Respir J 2005;26:835-45.
13. Rutgers SR, Postma DS, ten Hacken NH, et al. Ongoing airway inflammation in patients with COPD who do not currently smoke. Thorax 2000;55:12-8.
14. Lapperre TS, Postma DS, Gosman MM, et al. Relation between duration of smoking cessation and bronchial inflammation in COPD. Thorax 2006;61:115-21.
15. Vende S, Waterer GW, Tolley EA, et al. Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjects. Thorax 2006;61:10-6.
16. Thomas RA, Green RH, Brightling CE, et al. The influence of age on induced sputum differential cell counts in normal subjects. Chest 2004;126:4049-50.
17. Buckland A, Connolly MJ. Age-related differences in smoking cessation advice and support given to patients hospitalized with smoking-related illness. Age Ageing 2005;34:639-42.